ET01 - Clinical Practice Guidelines Elevate the Need for Ready-to-use Glucagon

Join Xeris Pharmaceuticals® for a presentation on making ready-to-use glucagon a standard of care and practice for patients taking hypoglycemic agents for diabetes. Hypoglycemia can occur unpredictably in patients with diabetes and can progress to severe hypoglycemia if left untreated. It is crucial for patients to have ready-to-use glucagon available for severe events.

https://www.gvokeglucagon.com/hcp#important-safety-information

https://www.gvokeglucagon.com/wp-content/uploads/2023/07/gvoke-prescribing-information-1.pdf

Please note: this session is not eligible for Continuing Education credit.